These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2465645)

  • 41. Late renal failure due to prostatic outflow obstruction: a preventable disease.
    Sacks SH; Aparicio SA; Bevan A; Oliver DO; Will EJ; Davison AM
    BMJ; 1989 Jan; 298(6667):156-9. PubMed ID: 2466506
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dilation of the prostate with 120 French balloon dilators for the treatment of benign prostatic hyperplasia: a technological advance.
    Reddy PK; Evans R; Kapoor DA
    Semin Urol; 1992 Nov; 10(4):257-9. PubMed ID: 1283023
    [No Abstract]   [Full Text] [Related]  

  • 43. [Shape memory alloy spiral for urethrostenosis caused by benign prostatic hyperplasia].
    Qiu CY
    Zhonghua Wai Ke Za Zhi; 1993 May; 31(5):272-4. PubMed ID: 7509268
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment of benign prostatic hyperplasia using transurethral split of the prostate with a columnar balloon catheter.
    Huang W; Guo Y; Xiao G; Qin X
    J Endourol; 2015 Mar; 29(3):344-50. PubMed ID: 25285775
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ultrasonographic and pathologic changes in the prostate of patients with benign prostatic hyperplasia after transurethral balloon laser therapy.
    Furuya S; Ogura H; Tsukamoto T; Kumamoto Y; Daikuzono N; Liong ML
    J Endourol; 1995 Aug; 9(4):325-31. PubMed ID: 8535462
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prostatic urethra dilatation with the Gianturco self-expanding metallic stent: a feasibility study in cadaver specimens and dogs.
    Dobben RL; Wright KC; Dolenz K; Wallace S; Gianturco C
    AJR Am J Roentgenol; 1991 Apr; 156(4):757-61. PubMed ID: 1706138
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [A new generation of urethral stents--Allium in the therapy of symptomatic prostatic enlargement of various etiology].
    Marković BB; Marković Z; Yachia D; Hadzi DJ
    Acta Chir Iugosl; 2007; 54(3):71-6. PubMed ID: 17988035
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Balloon dilatation of the prostate--should it have a place in the urologist's armamentarium?
    Vale JA; Miller PD; Kirby RS
    J R Soc Med; 1993 Feb; 86(2):83-6. PubMed ID: 7679443
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transurethral vaporization of the prostate in the treatment of bladder outlet obstruction at two university hospitals.
    Gerber GS; Jahoda A; Bales GT; Albala DM
    Tech Urol; 1997; 3(1):25-9. PubMed ID: 9170221
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Local prostatic hyperthermia in the therapy of urinary obstruction caused by prostatic adenoma. Experimental, clinico histologic and structural findings].
    Rigatti P; Guazzoni G; Montorsi F; Colombo R; Di Girolamo V
    Minerva Chir; 1990 Mar; 45(6):387-94. PubMed ID: 1693418
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fogarty balloon catheter ablation of neonatal posterior urethral valves.
    Diamond DA; Ransley PG
    J Urol; 1987 Jun; 137(6):1209-11. PubMed ID: 3586157
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High-energy transurethral microwave thermotherapy in men with lower urinary tract symptoms.
    d'Ancona FC; Francisca EA; Debruyne FM; de la Rosette JJ
    J Endourol; 1997 Aug; 11(4):285-9. PubMed ID: 9376850
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of benign prostatic hyperplasia using transurethral microwave thermotherapy and dilatation with double-balloon catheter.
    Tsukada O; Murakami M; Kosuge T; Yokoyama H
    J Endourol; 2005 Oct; 19(8):1016-20. PubMed ID: 16253073
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transrectal ultrasound parameters: presumed circle area ratio and transitional zone area in the evaluation of patients with lower urinary tract symptoms.
    Desai MM
    J Endourol; 1999 May; 13(4):317-21. PubMed ID: 10405914
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Temporary placement of a covered, retrievable, barbed stent for the treatment of hormone-induced benign prostatic hyperplasia: technical feasibility and histologic changes in canine prostates.
    Yoon CJ; Song HY; Kim JH; Park HG; Kang HS; Ro JY; Hong JH
    J Vasc Interv Radiol; 2010 Sep; 21(9):1429-35. PubMed ID: 20688535
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Retropublic extraperitoneal laparoscopic prostatectomy with urethra preservation].
    Yang FY; Xing NZ; Wang JW; Zhang JH; Guo YL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2010 Aug; 42(4):469-72. PubMed ID: 20721267
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Fabian's spiral endoprostatic prosthesis].
    Garbit JL; Blitz M; Bomel J; Pin P; Paillot J
    J Urol (Paris); 1988; 94(5-6):265-7. PubMed ID: 2461995
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Urethrocystography in a case of hypertrophy of the middle lobe of prostatic adenoma].
    Staniaszczyk R; Monita W; Pawlak C
    Pol Przegl Radiol; 1984; 48(6):421-2. PubMed ID: 6085739
    [No Abstract]   [Full Text] [Related]  

  • 59. Re: Bladder outflow tract obstruction and urinary retention from benign prostatic hypertrophy treated by balloon dilatation.
    Klein L
    Br J Urol; 1990 Oct; 66(4):443. PubMed ID: 1699630
    [No Abstract]   [Full Text] [Related]  

  • 60. Prostatic urethral lift improves urinary symptoms and flow while preserving sexual function for men with benign prostatic hyperplasia: a systematic review and meta-analysis.
    Perera M; Roberts MJ; Doi SA; Bolton D
    Eur Urol; 2015 Apr; 67(4):704-13. PubMed ID: 25466940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.